Science Explorer Back to mapMap
Discussion
Topic · Infectious Diseases

Antifungal resistance and susceptibility

Antifungal resistance and susceptibility is a research topic within Infectious Diseases. Science Explorer counts 43k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers covers the diagnosis, management, epidemiology, and treatment of various fungal infections such as candidiasis, aspergillosis, mucormycosis, and biofilm-related infections. It also discusses antifungal therapy, resistance mechanisms, and the impact of these infections on immunocompromised patients.

  • Invasive Fungal Infections
  • Candidiasis
  • Aspergillosis
  • Antifungal Therapy
  • Mucormycosis
  • Biofilm Formation
  • Antifungal Resistance
  • Epidemiology
  • Immunocompromised Patients
  • Diagnostic Methods
Research works
43k
fractional, since 1950
In the world top 10%
4.2k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+15%
the tick is no change
Largest producer
United States
28% of the 10 largest, 2022-now
Antifungal resistance and susceptibility

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Antifungal resistance and susceptibility research?

By volume, the United States and India publish the most (1.7k and 1.3k works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.7k works
  2. 2 India 1.3k works
  3. 3 China 1.1k works
  4. 4 Brazil 491 works
  5. 5 Japan 306 works
  6. 6 United Kingdom 273 works
  7. 7 Spain 247 works
  8. 8 France 231 works
  9. 9 Iran 231 works
  10. 10 Germany 190 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 28.4%India: 21.4%China: 18.1%Brazil: 8.0%6 others listed: 24.1%28%largest
United States1,745 · 28.4%India1,315 · 21.4%China1,113 · 18.1%Brazil491 · 8.0%6 others listed1,477 · 24.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Antifungal resistance and susceptibility research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Antifungal resistance and susceptibility research, followed by Post Graduate Institute of Medical Education and Research and Universidade de São Paulo.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 108 works
  2. 2 Post Graduate Institute of Medical Education and ResearchIndia 63 works
  3. 3 Universidade de São PauloBrazil 46 works
  4. 4 Mayo ClinicUnited States 37 works
  5. 5 Harvard UniversityUnited States 36 works
  6. 6 University of California, Los AngelesUnited States 35 works
  7. 7 Radboud University NijmegenNetherlands 33 works
  8. 8 Zhejiang UniversityChina 32 works
  9. 9 University of DelhiIndia 31 works
  10. 10 Tehran University of Medical SciencesIran 31 works

Who are the leading researchers in Antifungal resistance and susceptibility?

The most-cited researchers publishing on Antifungal resistance and susceptibility include Shizuo Akira, Jun Wang and John P. A. Ioannidis.

  1. 1 Shizuo Akira Japan 342k citations
  2. 2 Jun Wang China 340k citations
  3. 3 John P. A. Ioannidis United States 317k citations
  4. 4 Róbert Langer United States 303k citations
  5. 5 Peter Christian Gøtzsche Denmark 292k citations
  6. 6 Jeremy Grimshaw Canada 281k citations
  7. 7 Hagop M. Kantarjian United States 273k citations
  8. 8 Jean‐Louis Vincent Belgium 262k citations
  9. 9 Ben Zhong Tang China 261k citations
  10. 10 Amirhossein Sahebkar Iran 258k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Antifungal resistance and susceptibility?

The most cited paper in Antifungal resistance and susceptibility is "Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group" (Ben de Pauw et al., 2008), with 4,957 citations. Next come "Hidden Killers: Human Fungal Infections" (4,407) and "Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem" (4,219).

Most cited papers
#PaperReleasedCitations
1 Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Ben de Pauw et al. · Clinical Infectious Diseases Open access 7 May 2008 4,957
2 Hidden Killers: Human Fungal Infections Gordon D. Brown, David W. Denning, Neil A. R. Gow et al. · Science Translational Medicine Open access 19 Dec 2012 4,407
3 Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem Michael A. Pfaller, Daniel J. Diekema · Clinical Microbiology Reviews Open access 2007 4,219
4 Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Peter G. Pappas, Carol A. Kauffman, David R. Andes et al. · Clinical Infectious Diseases Open access 16 Dec 2015 4,217
5 J Antimicrob Chemother 1994; 33: 350–351 Elizabeth M. O’Shaughnessy, SATYA S. DAS · Journal of Antimicrobial Chemotherapy 1994 3,753
All 99 most cited papers, with filters and sorting

Where is Antifungal resistance and susceptibility research done?

The largest centres of Antifungal resistance and susceptibility research in 2022-now are New Delhi (India), Beijing (China), São Paulo (Brazil) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Jena, Chandigarh and Raipur.

Largest cities, 2022-now

  1. 1 New DelhiIndia 147 works
  2. 2 BeijingChina 143 works
  3. 3 São PauloBrazil 118 works
  4. 4 ParisFrance 104 works
  5. 5 ShanghaiChina 102 works
  6. 6 TokyoJapan 88 works
  7. 7 TehranIran 87 works
  8. 8 LondonUnited Kingdom 79 works
  9. 9 MadridSpain 79 works
  10. 10 GuangzhouChina 76 works

Where it is the local speciality

  1. JenaDE · 31.7 works8.7×
  2. ChandigarhIN · 69.2 works7.7×
  3. RaipurIN · 31.6 works7.3×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Antifungal resistance and susceptibility than the world average.

See Antifungal resistance and susceptibility on the map

Where is the best place to study Antifungal resistance and susceptibility?

Among universities, judged by research, University of Exeter, Radboud University Nijmegen and Universidad de Guanajuato score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 24.68%fractional works in this field (log) →share of work in the world top 10% →Universidad de Guana…University of Manche…University of ExeterRadboud University N…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University of ExeterUnited Kingdom 72.524.9%7.9×25 +91.7%
2Radboud University NijmegenNetherlands 69.624.5%7.2×33 -14.5%
3Universidad de GuanajuatoMexico 67.337.6%11.0×12 +41.1%
4University of ManchesterUnited Kingdom 64.925.2%3.1×20 +20.3%
5Tongji UniversityChina 63.926.1%2.3×27 +96.5%
6University of GuelphCanada 60.124.7%4.4×10 +43.1%
7University of LausanneSwitzerland 59.625.6%3.3×11 -5.1%
8University of GeorgiaUnited States 59.525.6%4.6×15 +63.7%
9University of California, Los AngelesUnited States 59.015.6%4.0×35 +4.7%
10Johns Hopkins UniversityUnited States 57.317.0%2.3×28 +12.5%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Antifungal resistance and susceptibility, country by country

Is Antifungal resistance and susceptibility research growing?

Output in 2022-2025 was 15% higher than in 2018-2021, peaking in 2022. The fastest-growing topics are Antifungal resistance and susceptibility.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Antifungal resistance and susceptibility as a percentage of every work published that year, 0.035% in 2024.

still counting0.020%0.040%0.060%Antifungal resistance and susceptibility0.034% in 202519801990200020102020

Fractional works of Antifungal resistance and susceptibility over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Antifungal resistance and susceptibility9.9% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Antifungal resistance and susceptibility. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.